Birkenmeier et al., “Complex patterns of sequence variation and multiple 5′ and 3′ ends are found among transcripts of the erythroid ankyrin gene,” Journal of Biological Chemistry, 268(13):9533-9540 (May 1993). |
Genbank® Accession No. M60847 for Mouse lipoprotein lipase (LPL) gene, exon 10. |
Genbank® Accession No. X54209 for cloning vector pRSET6d (pBluescript KS plus derivative). |
Genbank® Accession No. X69065, for M. musculus Ank-1 mRNA for erythroid ankyrin. |
Lewis et al., “Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific,” Proc. Natl. Acad. Sci. USA., 88:2830-2834 (Apr. 1991). |
Schoepfer et al., “The pRSET family of T7 promoter expression vectors for escherichia coli,” Gene, 124:83-85 (1993). |
Shalaby et al., “Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors,” (Abstract 170065U), Chemical Abstracts, 113(19):534 (Nov. 1990). |
Wallace et al., “Oligonucleotide probes for the screening of recombinant DNA libraries,” Methods in Enzymology, 152:432-442 (1987). |
Zechner et al., “The structure of the mouse lipoprotein lipase gene: A B1 repetitive element is inserted into the 3′ untranslated region of the mRNA,” Genomics, 11(1):62-76 (Sep. 1991). |
Adams, M.D., et al. “Initial Assessment of Human Gene Diversity and Expression Patterns Based Upon 83 Million Nucleotides of cDNA Sequence” Nature 377 (6547 Suppl.):3-174 (1995). |
Beltinger, C.P., et al. “Physical Mapping and Genomic Structure of the Human TNFR2 Gene” Genomics 35(1):94-100 (1996). |
Dembic, A. et al., “Two Human TNF Receptors Have Similar Extracellular, But Distinct Intracellular, Domain Sequences” Cytokine 2(4):231-237 (1990). |
Engelmann, H. et al., “Two Tumor Necrosis Factor-binding Proteins Purified from Human Urine” J. Biol. Chem. 265(3):1531-1536 (1990). |
Gabay, C. et al. “Circulating Levels of Tumor Necrosis Factor Soluble Receptors in Systemic Lupus Erythematosus are Significantly Higher Than in Other Rheumatic Diseases and Correlated with Disease Activity” J. Rheumatol. 24:303-308 (1997). |
GenBank® Accession No. 135962 for Tumor Necrosis Factor Receptor 2 Precursor (Tumor Necrosis Factor Binding Protein 2). |
GenBank® Accession No. 2072181 for Rat osteoprotegerin (OPG) protein. |
GenBank® Accession No. 207183 for Mouse osteoprotegerin (OPG) protein. |
GenBank® Accession No. 207185 for Human osteoprotegerin (OPG) protein. |
GenBank® Accession No. 235649 for tumor necrosis factor receptor, TNF receptor=75-kda. |
GenBank® Accession No. AA072902 for Stratagene mouse macrophage (#937306) Mus musculus cDNA clone 533995 5′. |
GenBank® Accession No. AA181032 for Stratagene endothelial cell 937223 Homo sapiens cDNA clone 625115 3′. |
GenBank® Accession No. AA239755 for GuayWoodford Beier mouse kidney day 0 Mus musculus cDNA clone 656082 5′. |
GenBank® Accession No. AA271351 for Soares mouse NML Mus musculus cDNA clone 738231 5′. |
GenBank® Accession No. AA351536 for Infant brain Homo sapiens cDNA. |
GenBank® Accession No. AA357231 for LNCAP cells I Homo sapiens cDNA. |
GenBank® Accession No. AA374471 for HSC172 cells I Homo sapiens cDNA. |
GenBank® Accession No. AA554244 for NCI_CGAP_Co3 Homo sapiens cDNA clone IMAGE:1029164 3′. |
GenBank® Accession No. AA555059 for NCI_CGAP_-Coll Homo sapiens cDNA clone IMAGE:1015210 3′. |
GenBank® Accession No. AA621819 for NCI_CGAP_Co10 Homo sapiens cDNA clone IMAGE:1144858 3′, mRNA sequence. |
GenBank® Accession No. D59902 for Human fetal brain cDNA 5′-end GEN-073E08. |
GenBank® Accession No. N49208 for Soares_multiple_sclerosis_2NbHMSP Homo sapiens cDNA clone 280262 3′. |
GenBank® Accession No. N50261 for Soares_multiple_sclerosis_2NbHMSP Homo sapiens cDNA clone 280262 5′. |
GenBank® Accession No. R74815 for Mouse brain, Stratagene Mus musculus cDNA 3′ end. |
Gruss, H-J. and S.K. Dower, “Tumor Necrosis Factor Ligand Superfamily: Involvement in the Pathology of Malignant Lymphomas” Blood 85(12):3378-3404 (1995). |
Heller, R.A. et al., “Complementary DNA Cloning of a Receptor for Tumor Necrosis Factor and Demonstration of a Shed Form of the Receptor” Proc. Natl. Acad. Sci. USA 87(16):6151-6155 (1990). |
Itoh, N. and S. Nagata, “A Novel Protein Domain Required for Apoptosis” The Journal of Biochemistry 268(15):10932-10937 (1993). |
Kohno, T. et al., “A Second Tumor Necrosis Factor Receptor Gene Product Can Shed a Naturally Occurring Tumor Necrosis Factor Inhibitor” Proc. Natl. Acad. Sci. USA 87(21):8331-8335 (1990). |
Loetscher, H. et al., “Purification and Partial Amino Acid Sequence Analysis of Two Distinct Tumor Necrosis Factor Receptors from HL60 Cells” J. Biol. Chem. 265(33):20131-20138 (1990). |
Naismith, J.A. and S.R. Sprang, “Tumor Necrosis Factor Receptor Superfamily” J. Inflamm. 47:1-7 (1996). |
Pennica, D. et al., “Biochemical Properties of the 75-kDa Tumor Necrosis Factor Receptor: Characterization of the Ligand Binding, Internalization, and Receptor Phosphorylation” The Journal of Biological Chemistry 267(29):21172-21178 (1992. |
Reddi, A.H., “Bone Morphogenesis and Modeling: Soluble Signals Sculpt Osteosomes in the Solid State” Cell 89:159-161 (1997). |
Simonet, W.E. et al., “Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density” Cell 89(2):309-319 (1997). |
Smith, C.A. et al., “A Receptor for Tumor Necrosis Factor Defines an Unusual Family of Cellular and Viral Proteins” Science 248(4958):1019-1022 (1990). |
Tartaglia, L.A. et al., “A Novel Domain within the 55 kd TNF Receptor Signals Cell Death” Cell 74:845-853 (1993). |